Abstract
Like all therapeutics, cancer chemotherapy began as a largely emperical effort with a major emphasis on the interplay between serendipity and screening. The first major point I would like to make in this presentation is that a scientific base for cancer chemotherapy and for the construction of clinical trials has developed rapidly in the past five to 15 years. Basic research on the nature of the neoplastic cell has provided an increasing number of leads with respect to therapeutic targets exploitable by chemotherapy and immunotherapy (Fig. 1). The sciences of pharmacology and its subsets and of cytokinetics and biostatistics, uhich some refer to as “bridging sciences”, now impinge daily and importantly on the development and application of chemotherapeutic programs to man (Fig. 1). I would like to cite one important recent example that relates to structure activity studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Di Marco, A., & Lenaz, L. Daunomycin and Adriamycin. In Cancer Medicine, Eds. J.F. Holland and E. Frei III, Lea & Febiger, Philadelphia, 1973, pp. 826–835.
Blum, R.H. & Carter S.K. A new cancer drug with significant clinical activity. Ann. Internal Med. 80, 249–259, 1974.
Pigram, W.J., Fuller, W. & Hamilton, L.D. Stereochemistry of intercalation: interaction of daunomycin with DNA. Nature New Biol. 235: 17–19, 1972.
Skipper, H.E., Schabel, F.M. Jr. Quantitative and cytokinetic studies in experimental tumor models. In Cancer Medicine, Eds. J.F. Holland, E. Frei III, Lea & Febiger, Philadelphia, 1973, pp. 629–650.
Hakala, M.T. Transport of antineoplastic agents. In Antineoplastic and Immunosuppressive Agents. Chapter 13, pp. 240–269, 1974.
Tannock, I.F. The relation between cell proliferation and the vascular system in transplanted mouse mammary tumour. Brit. J. Cancer, 22: 258–273, 1968.
Djerassi, I., Rominger, C. J. Kim, J.S. et al. Phase I study of high doses of methotrexate with citrovorum factor in patients uith lung cancer. Cancer 30:22–30, 1972.
Jaffe, N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30:1627–1631, 1972.
Cortes, E.P., Holland, J.F., Wang, J.J. et al. Doxorubicin in disseminated osteosarcoma. JAMA 221:1132–1138, 1972.
Frei, E III, Jaffe, N, Tattersall, M.H.N., Pitman, S. New approaches to cancer chemotherapy with methotrexate. New Engl. J. Med. 292: 846–851, April 17, 1975.
Fisher, B., Carbone, P., Economou, S.G. et al. l-Phen-ylalanine mustard (L-PAM) in the management of breast cancer: A report of early findings. New Engl. J. Med. 292:117–122, 1975.
Canellos, G.P., Taylor, S.G. III., Band, P. & Pocock, S. Combination chemotherapy for advanced breast cancer: randomized comparison with single drug therapy. Prox. XI Intern. Cancer Congress 3:596, 1974 (abstr.)
Frei, E. III. Combination cancer therapy: Presidential address. Cancer Research Vol 32:2593–2607, 1972.
Sartorelli, A.C. Combination chemotherapy. Cancer Medicine, Eds. J.F. Holland and E. Frei III, Lea & Febiger, Philadelphia, 1973, pp. 706–716, 1973.
Easson, E.C. & Russel, M.H. The cure of Hodgkin’s disease. Brit. J. Med. 1:1704–1707, 1963.
DeVita, V.T. Jr., Canellos, G.P., Chabner, B. et al. Advanced diffuse histiocytic lymphoma, a potentially curable disease: results with combination chemotherapy. Lancet 1:248–250, 1975.
Skarin, A., Rosenthal, D., Moloney, W. & Frei, E.III. Treatment of advanced non-Hodgkin’s lymphoma (NHL) with bleomycin (B), adriamycin (A), cyclophosphamide (C) and vincristine (O) and prednisone (P)(BAC0P), AACR/ASCO Proceedings 15:133, 1974.
Gottlieb, J., Baker, L.H., O’Brien, R.M. et al. Adriamycin used alone and in combination in soft tissue and bone sarcomas. Cancer Chemotherapy Reports (In press).
Frei, E. III & Freireich, E.J. Progress and perspective in the chemotherapy of acute leukemia. Advances Chemother. 2:269, 1965.
Ansfield, F.J. A randomized phase III study of four dosaoes reoimens of 5-fluorouracil — A preliminary report. 11th Annual Meeting of the American Society of Clinical Oncology, Abstract 1014, p. 224, 1975.
Sallan, S., Zinberg, N., Frei, E, III. Oral delta-9-tetrahydrocannabinol (THC) in the prevention of vomiting (V) associated with cancer chemotherapy (CC) 66th Annual Meeting of the American Association for Cancer Research, Abstract 575, p. 144, 1975.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Frei, E. (1976). Advances in Cancer Chemotherapy. In: Hellmann, K., Connors, T.A. (eds) Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4349-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4349-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4351-6
Online ISBN: 978-1-4613-4349-3
eBook Packages: Springer Book Archive